🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this protocol is to compare PDE4 levels before and a...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2006-08-02
Trial ID
NCT00369798
This phase II trial studies how well onvansertib in combination with gemcit...
Status
Withdrawn
Location
OHSU Knight Cancer Institute
Start Date
2024-08-01
Trial ID
NCT06398587
This phase II trial studies how well the addition of olaparib to the usual ...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2021-03-17
Trial ID
NCT04394858
This phase I trial tests the safety, side effects, and best dose of combina...
Status
Recruiting
Location
Los Angeles General Medical Center
Start Date
2024-02-06
Trial ID
NCT05711615
Recent data show that marked cell damage precedes the clinical manifestatio...
Status
Completed
Location
NYU School of Medicine, Dept. of Psychiatry, Center for Brain Health
Start Date
2009-07
Trial ID
NCT00933608
The purpose of this study is to see whether magnetic resonance (MR) techniq...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2006-08
Trial ID
NCT00578838
Treatments Being Tested
This phase I trial tests the safety, side effects, best dose of MUC1-activa...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2024-09-20
Trial ID
NCT06483048
The purpose of this study is to compare a rapid noncontrast MRI protocol no...
Status
Withdrawn
Location
University of Michigan
Start Date
2012-02
Trial ID
NCT01588340
Treatments Being Tested
This randomized phase III trial studies how well paclitaxel, trastuzumab, a...
Status
Terminated
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-04-05
Trial ID
NCT03199885
The purpose of this research study is to evaluate a new drug pembrolizumab ...
Status
Unknown
Location
Stanford Cancer Institute
Start Date
2017-11-09
Trial ID
NCT03226249